Track topics on Twitter Track topics that are important to you
1435 Kensington Square Court
United States of America
A look at today's forthcoming news stories: GSK has stepped up its drive into emerging markets; an over the counter genetic testing kit is launched in the US, and the head of BioVentures for Global He...
But elephant in the room – the coming stream of readouts from Phase III PIONEER trials on oral semaglutide in...
The introduction of new listing rules in Hong Kong makes it easier for biotech companies to go public and provides...
Intact Vascular Inc. (devices for minimally invasive peripheral vascular procedures) raised $20mm in its Series C financing to New Enterprise Associates, HIG BioVentures, and Quaker Partners. The fund...
Wells Fargo analyst David Maris warned biopharma investors that the US drug market is on a long-term trajectory toward price...
In this episode of PharmaTelevision News Review, filmed at #BIO2012 Convention in Boston, Fintan Walton talks to Don Joseph, CEO of BioVentures for Global Health about the role of BVGH and their new ...
Ansun BioPharma Inc. (developing antiviral biologics for respiratory tract infections) raised $85mm in a Series A financing led by Sinopharm Healthcare Fund and Lilly Asia Ventures, which each add a b...
Metabolic disease-focused Hua Medicine Ltd. raised $50mm in its oversubscribed Series C financing led by Harvest Investments and Frontline BioVentures, which were joined by returning shareholders Arch...
Frontline BioVentures is a China-based premier venture capital firm specializing in investments in innovative life science companies. It focuses on business within strategic life ...
BioVentures, Inc. is committed to the highest levels of scholarship through the submission of original research to peer reviewed publications and presentation of our data at scientific conferences. In...
Alpine BioVentures is a venture capital firm committed to investing in and building revolutionary healthcare companies. It brings a unique perspective to identify game-changing sc...
Headquartered near Research Triangle Park, NC, APR is majority owned and virtually run by Cato BioVentures. APR will work with Advanced Targeting Systems, Cato Research and Cato BioVentures to develop...
HTI was formed in 2004 as a majority-owned portfolio company of Cato BioVentures. Through its strategic development relationship with Cato BioVentures and its contract research and development affilia...
We have published hundreds of BioVentures, Inc. news stories on BioPortfolio along with dozens of BioVentures, Inc. Clinical Trials and PubMed Articles about BioVentures, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioVentures, Inc. Companies in our database. You can also find out about relevant BioVentures, Inc. Drugs and Medications on this site too.